Gastroenterology
Volume 122, Issue 1 , Pages 230-233, January 2002

The cost-effectiveness of aspirin for chemoprevention of colorectal cancer☆

Duke University Medical School, Durham, North Carolina

Abstract 

GASTROENTEROLOGY 2002;122:230-233

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ Address requests for reprints to: Dawn Provenzale, M.D., M.S., 508 Fulton Street, Building 16, Room 70, Durham, North Carolina 27705. fax: (919) 416-5839.

PII: S0016-5085(02)70167-4

Refers to article:

  • Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis

    Saud Suleiman, Douglas K. Rex, Amnon Sonnenberg
    Gastroenterology January 2002 (Vol. 122, Issue 1, Pages 78-84)

Gastroenterology
Volume 122, Issue 1 , Pages 230-233, January 2002

Article Tools